AleStat.com

natap.org  Show on alexa natap.org  Redirect to natap.orgdelete
National AIDS Treatment Advocacy Project - NATAP - HIV - AIDS Treatment Information

Local position Global website us 374 097
Global position 765 491
United States » Society » Issues » Health » Conditions and Diseases » Sexually Transmitted Diseases » AIDS » Treatment Activism » Organizations
United States » Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Regional » North America » United States » New York
United States » Health » Conditions and Diseases » Immune Disorders » Immune Deficiency » AIDS » Treatment and Therapies
  • natap.org
  • Unique daily visits 764
    Unique daily views 993
  • Observe
  • Average load page none
    IP address 216.92.100.202
    Last update website 6 years ago
  • Alexa rank from last month (top 1m)

    Compare natap.org to:

  • Which websites did users visit before enter the natap.org

    google.com 39.13%
  • Which websites did users visit after leaving the natap.org


    google.com 38.10%
  • Pages indexed at

    Yahoo 35
    Bing 33
  • Backlinks

    Yahoo none
    Bing none
    Alexa 626
  • Social media

    Facebook 47
    Twitter 17
  • Site info

    Title

    National AIDS Treatment Advocacy Project - NATAP - HIV - AIDS Treatment Information

    Description

    Natap's web site is a leader in up-to-the minute HIV treatment information, covering the latest in drug development and research, comprehensive conference reports, and in-depth articles on HIV treatments. NATAP's newsletter, Protease Inhibitor User's Guide, and other publications are all available on the site

    Keywords

    protease inhibitors, HIV, AIDS, treatment, Hep C, hepatitis, Hepatitis C, HCV, coinfection, co-infection, IVDU, peg-intron, Interferon, liver, Ribavirin, Pegylated Interferon, Pegasys, genotype, experimental, nucleosides, non-nucleosides, drug therapies, HIV drugs, adherence, compliance, viral load, 50 copies, proviral DNA, RNA, 4 drugs, Efavirenz, DMP-266, salvage therapy, 1592U89, Abacavir, t-20, fusion inhibitor, PMEA, MKC-442, resistance, double protease, Crixivan, indinavir, Viracept, nelfi

Ważne: nasze strony wykorzystują pliki cookies.

Bez tych plików serwis nie będzie działał poprawnie. W każdej chwili, w programie służącym do obsługi internetu, można zmienić ustawienia dotyczące cookies. Korzystanie z naszego serwisu bez zmiany ustawień oznacza, że będą one zapisane w pamięci urządzenia. Więcej informacji w Polityce prywatności.

Zapoznałem się z informacją